Skip to content
Homepage
Author:
ALX Oncology
Posted Date:
August 6, 2026
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update
ALX Oncology
August 6, 2026
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ALX Oncology
June 30, 2026
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
ALX Oncology
June 30, 2026
